12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks showed significant movement. TC BioPharm, Dyadic International, and Mesoblast were among the top gainers, with shares increasing by 74.5%, 21.73%, and 19.53% respectively. On the losing end, Ainos, Nexalin Technology, and Fortrea Holdings saw their shares fall by 15.6%, 11.64%, and 10.32% respectively. These movements reflect the dynamic nature of the healthcare stock market, influenced by factors such as quarterly earnings reports.
March 11, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ainos shares fell 15.6% to $1.73, with a market cap of $8.0 million, following their Q4 earnings release.
The decline in AIMD shares post-earnings suggests a negative market reaction, likely leading to short-term bearish sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Fortrea Holdings shares fell 10.32% to $33.03, with a market cap of $2.9 billion, following their Q4 earnings release.
FTRE's post-earnings drop indicates a negative reception to their Q4 results, suggesting short-term downward pressure on the stock.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Nexalin Technology shares decreased by 11.64% to $0.43, with a market cap of $3.1 million.
The drop in NXL shares could reflect investor concerns, potentially leading to further short-term declines.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Dyadic International stock rose 21.73% to $1.68, with a market cap of $48.4 million.
DYAI's notable pre-market rise indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Mesoblast shares increased by 19.53% to $2.57, with a market cap of $260.8 million.
The rise in MESO shares suggests strong investor confidence, potentially leading to more short-term upward movement.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
TC BioPharm shares surged 74.5% to $1.85, with a market cap of $4.4 million.
The significant increase in TCBP's share price could attract investor interest, potentially leading to short-term price volatility.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90